A 68-year-old man is discharged after an NSTEMI treated with percutaneous coronary intervention and a drug-eluting stent. He has normal renal function and no history of major bleeding. In addition to a statin, beta blocker and ACE inhibitor, which antiplatelet regimen is most appropriate on discharge?